Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Seminars in Oncology
|
June 29, 2013
Chemotherapy and targeted therapies: are we making progress in castrate-resistant prostate cancer?
Jean Hoffman-Censits, Maofu Fu
Current Opinion in Urology
|
August 13, 2016
Combination immunotherapy in genitourinary malignancies
Jean Hoffman-Censits, Lindsay Wilde
Oncotargets and Therapy
|
December 22, 2022
Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context
Jean Hoffman-Censits, Laneisha Maldonado
The Urologic Clinics of North America
|
August 3, 2010
Chemotherapy for penile and urethral carcinoma
Edouard J Trabulsi, Jean Hoffman-Censits
Clinical Genitourinary Cancer
|
May 20, 2015
Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma
Jean Hoffman-Censits, Yu-Ning Wong
Oncotargets and Therapy
|
September 2, 2017
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
Sheel A Patel, Jean Hoffman-Censits
The Canadian Journal of Urology
|
April 30, 2014
Practical guide to the use of enzalutamide
Jean Hoffman-Censits, Wm Kevin Kelly
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2013
Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer
Jean Hoffman-Censits, Wm Kevin Kelly
The Canadian Journal of Urology
|
December 21, 2017
Recurrent renal cell carcinoma presenting as a solitary left ventricular mass
Lindsay Wilde, Praveen Mehrotra, Jean Hoffman-Censits
European Urology Focus
|
August 21, 2025
Clinical Consultation Guide: Neoadjuvant Chemotherapy for Upper Tract Urothelial Cancer
Sean A Fletcher, Nirmish Singla, Jean Hoffman-Censits
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Seminars in Oncology
|
June 29, 2013
Chemotherapy and targeted therapies: are we making progress in castrate-resistant prostate cancer?
Jean Hoffman-Censits, Maofu Fu
Current Opinion in Urology
|
August 13, 2016
Combination immunotherapy in genitourinary malignancies
Jean Hoffman-Censits, Lindsay Wilde
Oncotargets and Therapy
|
December 22, 2022
Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context
Jean Hoffman-Censits, Laneisha Maldonado
The Urologic Clinics of North America
|
August 3, 2010
Chemotherapy for penile and urethral carcinoma
Edouard J Trabulsi, Jean Hoffman-Censits
Clinical Genitourinary Cancer
|
May 20, 2015
Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma
Jean Hoffman-Censits, Yu-Ning Wong
Oncotargets and Therapy
|
September 2, 2017
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
Sheel A Patel, Jean Hoffman-Censits
The Canadian Journal of Urology
|
April 30, 2014
Practical guide to the use of enzalutamide
Jean Hoffman-Censits, Wm Kevin Kelly
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2013
Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer
Jean Hoffman-Censits, Wm Kevin Kelly
The Canadian Journal of Urology
|
December 21, 2017
Recurrent renal cell carcinoma presenting as a solitary left ventricular mass
Lindsay Wilde, Praveen Mehrotra, Jean Hoffman-Censits
European Urology Focus
|
August 21, 2025
Clinical Consultation Guide: Neoadjuvant Chemotherapy for Upper Tract Urothelial Cancer
Sean A Fletcher, Nirmish Singla, Jean Hoffman-Censits
Page
of 8